BSE Live
Oct 10, 16:01Prev. Close
1763.10
Open Price
1702.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:49Prev. Close
1760.20
Open Price
1740.10
Bid Price (Qty.)
1741.80 (3)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Hester Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 | |
Diluted EPS (Rs.) | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 | |
Cash EPS (Rs.) | 47.52 | 43.42 | 49.52 | 57.62 | 58.23 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 398.60 | 367.59 | 343.70 | 315.54 | 279.28 | |
Book Value [InclRevalReserve]/Share (Rs.) | 398.60 | 367.59 | 343.70 | 315.54 | 279.28 | |
Dividend / Share(Rs.) | 7.00 | 6.00 | 8.00 | 10.00 | 10.00 | |
Revenue from Operations/Share (Rs.) | 336.74 | 335.20 | 298.58 | 257.85 | 245.07 | |
PBDIT/Share (Rs.) | 65.48 | 60.66 | 70.78 | 76.67 | 86.57 | |
PBIT/Share (Rs.) | 55.40 | 49.17 | 59.27 | 65.50 | 75.24 | |
PBT/Share (Rs.) | 49.09 | 43.18 | 51.63 | 62.60 | 64.40 | |
Net Profit/Share (Rs.) | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 19.44 | 18.09 | 23.70 | 29.73 | 35.32 | |
PBIT Margin (%) | 16.45 | 14.66 | 19.85 | 25.40 | 30.70 | |
PBT Margin (%) | 14.57 | 12.88 | 17.29 | 24.27 | 26.27 | |
Net Profit Margin (%) | 11.11 | 9.52 | 12.73 | 18.01 | 19.13 | |
Return on Networth / Equity (%) | 9.39 | 8.68 | 11.06 | 14.72 | 16.79 | |
Return on Capital Employed (%) | 10.48 | 9.25 | 12.31 | 15.93 | 25.87 | |
Return on Assets (%) | 5.83 | 4.94 | 5.92 | 9.31 | 14.14 | |
Total Debt/Equity (X) | 0.31 | 0.43 | 0.56 | 0.45 | 0.02 | |
Asset Turnover Ratio (%) | 0.52 | 0.52 | 0.52 | 0.62 | 73.92 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.92 | 2.09 | 1.58 | 2.22 | 4.03 | |
Quick Ratio (X) | 1.31 | 1.39 | 1.00 | 1.28 | 2.38 | |
Inventory Turnover Ratio (X) | 4.51 | 0.44 | 0.39 | 0.55 | 3.66 | |
Dividend Payout Ratio (NP) (%) | 16.02 | 25.05 | 26.30 | 21.52 | 14.07 | |
Dividend Payout Ratio (CP) (%) | 12.62 | 18.42 | 20.19 | 17.35 | 11.33 | |
Earnings Retention Ratio (%) | 83.98 | 74.95 | 73.70 | 78.48 | 85.93 | |
Cash Earnings Retention Ratio (%) | 87.38 | 81.58 | 79.81 | 82.65 | 88.67 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 1,168.78 | 1,310.43 | 1,451.81 | 2,429.84 | 1,633.72 | |
EV/Net Operating Revenue (X) | 4.08 | 4.60 | 5.72 | 11.08 | 7.84 | |
EV/EBITDA (X) | 20.98 | 25.39 | 24.11 | 37.25 | 22.18 | |
MarketCap/Net Operating Revenue (X) | 3.72 | 4.14 | 5.09 | 10.53 | 7.82 | |
Retention Ratios (%) | 83.97 | 74.94 | 73.69 | 78.47 | 85.92 | |
Price/BV (X) | 3.15 | 3.78 | 4.42 | 8.61 | 6.86 | |
Price/Net Operating Revenue | 3.72 | 4.14 | 5.09 | 10.53 | 7.82 | |
Earnings Yield | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
09.05.2025
Hester Bio Consolidated March 2025 Net Sales at Rs 81.93 crore, up 3.37% Y-o-Y
31.01.2025
Hester Bio Consolidated December 2024 Net Sales at Rs 63.22 crore, down 5.62% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
09.05.2025
Hester Bio Consolidated March 2025 Net Sales at Rs 81.93 crore, up 3.37% Y-o-Y
31.01.2025
Hester Bio Consolidated December 2024 Net Sales at Rs 63.22 crore, down 5.62% Y-o-Y